Servier
Servier is an international pharmaceutical company governed by a non-profit foundation and employs over 22,000 people worldwide. Servier is driven by constant search for innovation in five therapeutic areas – cancer (apoptosis and immuno-oncology), cardiovascular, immune-inflammatory, and neuropsychiatric diseases, and diabetes. Entirely independent, Servier has made oncology one of its priority areas and reinvests 35% (excluding generic drugs) of its turnover in research and development in oncology. Servier is committed to therapeutic progress to serve patient needs.